New York, December 30, 2011 – We are pleased to announce that BBH Capital Partners (“BBHCP”) has completed an investment in Microban International, Ltd. (“Microban” or the “Company”). Based in Charlotte, North Carolina, Microban is a market leader in the design, engineering, testing and marketing of highly engineered, built-in branded antimicrobial ingredient solutions for consumer, industrial and medical products around the world. BBHCP’s junior capital investment was used to support Microban’s acquisition by W.M. Barr & Company, Inc. (“W.M. Barr”), a leading marketer, developer and manufacturer of a full suite of branded specialty cleaning products for the home improvement, household, industrial and DIY automotive segments. W.M. Barr also contributed its antimicrobial division to Microban. David Meyers, Chief Executive of Microban, will continue in his role and will continue to be a shareholder of Microban. We were particularly attracted to Microban given its strong brand recognition, its focus on the rapidly growing market for antimicrobial and infection control solutions, its high customer retention rate, and its strong senior management team. The combination of W.M. Barr and Microban is expected to be highly synergistic as Microban benefits from W.M. Barr’s well established distribution channels.

About BBH Capital Partners

BBH Capital Partners typically invests $10 million to $50 million of growth equity and, when appropriate, junior debt securities in lower middle market companies in a variety of transactions including management or leveraged buyouts, growth financings, recapitalizations and acquisitions. Typically, BBH Capital Partners seeks to invest in companies with enterprise values up to $400 million. By investing in a variety of subordinated debt and equity securities in control and non-control transactions, BBH Capital Partners offers highly customized financing solutions for companies seeking capital.